KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Petmed Express (PETS) over the last 17 years, with Q4 2025 value amounting to $55.2 million.

  • Petmed Express' Total Liabilities rose 1355.25% to $55.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $55.2 million, marking a year-over-year increase of 1355.25%. This contributed to the annual value of $63.6 million for FY2025, which is 1310.54% down from last year.
  • Per Petmed Express' latest filing, its Total Liabilities stood at $55.2 million for Q4 2025, which was up 1355.25% from $57.2 million recorded in Q3 2025.
  • Over the past 5 years, Petmed Express' Total Liabilities peaked at $80.0 million during Q2 2023, and registered a low of $17.9 million during Q3 2021.
  • Its 5-year average for Total Liabilities is $51.5 million, with a median of $55.7 million in 2022.
  • As far as peak fluctuations go, Petmed Express' Total Liabilities skyrocketed by 22613.8% in 2023, and later crashed by 3367.31% in 2024.
  • Quarter analysis of 5 years shows Petmed Express' Total Liabilities stood at $27.5 million in 2021, then soared by 98.87% to $54.7 million in 2022, then soared by 33.88% to $73.3 million in 2023, then crashed by 33.67% to $48.6 million in 2024, then rose by 13.55% to $55.2 million in 2025.
  • Its Total Liabilities stands at $55.2 million for Q4 2025, versus $57.2 million for Q3 2025 and $58.3 million for Q2 2025.